| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |